Bioequivalence of a Generic Vortioxetine 20 mg Tablet in Healthy Mexican Volunteers Under Fasting Conditions
Pharmaceuticals · 16.07.2026 · 19 (7) · 1093
DOI: 10.3390/ph19071093 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 16.07.2026. Verfasst von Porfirio de la Cruz Cruz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Doctorado Institucional en Ingeniería y Ciencia de Materiales (DICIM), de la Universidad Autónoma de San Luis Potosí (UASLP), Av. Sierra Leona No. 55…. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Asofarma de México S.A. de C.V..
Abstract (Originalsprache)
Background/Objectives: Major Depressive Disorder (MDD) is a complex psychiatric condition characterized by persistent low mood and cognitive dysfunction. Vortioxetine, a multimodal antidepressant, modulates serotonin receptor activity and inhibits the serotonin transporter. This study aimed to evaluate the bioequivalence and in vitro dissolution performance of a generic 20 mg vortioxetine formulation compared to the reference product under fasting conditions in healthy Mexican volunteers.
Methods
This was a randomized, open-label, two-period, crossover study. Twenty healthy subjects were enrolled, and 18 completed both periods, with a 4-week washout period between them. Plasma concentrations were quantified using a validated LC-MS/MS method.
Results
The 90% confidence intervals (CI) for the geometric mean ratios (Test/Reference) of Cmax and AUC0–72 were 92.32% [84.51–100.85] and 96.77% [91.10–102.80], respectively. Both parameters fell within the 80.00–125.00% bioequivalence acceptance range. No serious adverse events were reported.
Conclusions
The generic vortioxetine formulation is bioequivalent to the reference product, supporting its therapeutic interchangeability for the treatment of MDD. NCT07624357.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Doctorado Institucional en Ingeniería y Ciencia de Materiales (DICIM), de la Universidad Autónoma de San Luis Potosí (UASLP), Av. Sierra Leona No. 550 Col. Lomas 2da. Sección, San Luis Potosí C.P. 78210, Mexico.
- FS SCIENTIA PHARMA S.A. de C.V. (Authorized Third Party), Fray Diego de la Magdalena 630, Jardín, San Luis Potosí C.P. 78270, Mexico.
- Asofarma de México S.A. de C.V., Av. Santa Fe 485, Lomas de Santa Fe, Contadero, Cuajimalpa de Morelos, Ciudad de México C.P. 05348, Mexico.
- Facultad de Ciencias Químicas, de la Universidad Autónoma de San Luis Potosí, Martínez #6, Av. Dr. Manuel Nava, Zona Universitaria, San Luis Potosí C.P. 78210, Mexico.
ORCID-Profile: Abraham Escobedo-Moratilla, José Trinidad Pérez Urizar
Förderung
- Asofarma de México S.A. de C.V.
Zitieren
APA
Cruz, P. C., Muñoz, A. M., Guido Ávila, E. G., Piña, O. E. H., Escobedo-Moratilla, A., & Urizar, J. T. P. (2026). Bioequivalence of a Generic Vortioxetine 20 mg Tablet in Healthy Mexican Volunteers Under Fasting Conditions. Pharmaceuticals, 19(7), 1093. https://doi.org/10.3390/ph19071093
Vancouver
Cruz PC, Muñoz AM, Guido Ávila EG, Piña OEH, Escobedo-Moratilla A, Urizar JTP. Bioequivalence of a Generic Vortioxetine 20 mg Tablet in Healthy Mexican Volunteers Under Fasting Conditions. Pharmaceuticals. 2026;19(7):1093. doi:10.3390/ph19071093
BibTeX
@article{Cruz2026,
author = {Cruz, Porfirio de la Cruz and Muñoz, Alberto Martínez and Guido Ávila, Erika Gabriela and Piña, Omar Emmanuel Hernández and Escobedo-Moratilla, Abraham and Urizar, José Trinidad Pérez},
title = {Bioequivalence of a Generic Vortioxetine 20 mg Tablet in Healthy Mexican Volunteers Under Fasting Conditions},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {7},
pages = {1093},
doi = {10.3390/ph19071093}
}
EUVIMED